Overview
Malignant eccrine spiradenoma is a rare, aggressive variant of eccrine spiradenoma, characterized by malignant transformation of sweat gland tumors. It typically presents as a deep-seated, painful mass with potential for local invasion and metastasis 12.Diagnosis
Biopsy revealing malignant transformation of eccrine spiradenoma cells
Immunohistochemical staining for markers indicative of malignancy (details not specified in abstracts)
Imaging (MRI, CT) to assess local invasion and potential metastasis
Histopathological examination confirming atypical cellular features and mitotic activity 12Management
Surgical excision with wide margins is essential for local control 12
Adjuvant radiotherapy may be considered for residual disease or high-risk features 12
Chemotherapy regimens are not well-defined; may include drugs targeting angiogenic pathways given VHL alterations 1Special Populations
Limited data; management principles likely similar across age groups but individualized care required 12
No specific recommendations for pregnancy or comorbidities noted 12Key Recommendations
Confirm diagnosis through histopathological examination with immunohistochemical analysis 12 (Evidence: Moderate)
Primary treatment should involve wide surgical excision to achieve local control 12 (Evidence: Moderate)
Consider adjuvant radiotherapy for high-risk features or incomplete resection 12 (Evidence: Moderate)References
1 Shiao YH. The von Hippel-Lindau gene and protein in tumorigenesis and angiogenesis: a potential target for therapeutic designs. Current medicinal chemistry 2003. link
2 Wang R, Bautch VL. The polyomavirus early region gene in transgenic mice causes vascular and bone tumors. Journal of virology 1991. link